GVT
ANGO icon

Genesee Valley Trust’s AngioDynamics ANGO Stock Holding History

Genesee Valley Trust’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-13,535
Closed -$186K – 285
2014
Q3 		$186K Buy
13,535
+170
+1% +$2.43K 0.12% 272
2014
Q2 		$218K Sell
13,365
-85
-0.6% -$1.23K 0.13% 267
2014
Q1 		$212K Sell
13,450
-85
-0.6% -$1.39K 0.13% 258
2013
Q4 		$232K Sell
13,535
-30
-0.2% -$462 0.15% 240
2013
Q3 		$179K Buy
+13,565
New +$160K 0.13% 274

Other funds holding ANGO

ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Genesee Valley Trust's ANGO Position: Q4 2014 in Review

Genesee Valley Trust sold out of AngioDynamics (ANGO) in Q4 2014, closing a stake of 13,535 shares — an estimated $186K sold.

Genesee Valley Trust first reported a position in ANGO in Q3 2013 and held it in 5 quarters. The position peaked at $232K in Q4 2013. 132 funds tracked by Wall St. Rank hold ANGO as of Q4 2014.

  • Genesee Valley Trust reported no remaining AngioDynamics position as of Q4 2014 after selling out during the quarter.
  • Genesee Valley Trust sold 13,535 AngioDynamics shares in Q4 2014, an estimated $186K.
  • Genesee Valley Trust first reported a position in AngioDynamics in Q3 2013 and held it in 5 quarters.
  • Genesee Valley Trust's AngioDynamics position peaked at $232K in Q4 2013.
  • 132 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2014.

Based on Genesee Valley Trust's 13F filing for Q4 2014, filed 12 Feb 2015.